Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence

World Journal of Surgery

Volumn 38, Issue 10, 2015, Pages 2698-2707

  Grąt, Michał ^a   Kornasiewicz, Oskar ^a   Lewandowski, Zbigniew ^a   Hołówko, Wacław ^a   Grąt, Karolina ^a   Kobryń, Konrad ^a   Patkowski, Waldemar ^a   Zieniewicz, Krzysztof ^a   Krawczyk, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; BLOOD; CARCINOMA, HEPATOCELLULAR; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY; TIME; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RETROSPECTIVE STUDIES; TIME FACTORS; TUMOR BURDEN;

EID: 84938830816     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2647-3     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Barbara L, Benzi G, Gaiani S et al (1992) Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 16:132-137
3. Shen A, Tang C, Wang Y et al (2013) A systematic review of sorafenib in Child-Pugh A patients with unresectable hepatocellular carcinoma. J Clin Gastroenterol 47:871-880
4. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245-1255
5. Ringe B, Pichlmayr R, Wittekind C et al (1991) Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15:270-285
6. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699
7. Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394-1403
8. Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35-43
9. Mailey B, Buchberg B, Prendergast C et al (2009) A disease-based comparison of liver transplantation outcomes. Am Surg 75:901-908
10. Singal AK, Guturu P, Hmoud B et al (2013) Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 95:755-760
11. Clavien PA, Lesurtel M, Bossuyt PM et al (2012) Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 13:e11-e22
12. Bruix J, Sherman M (2011) American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1022
13. European Association for Study of Liver; European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer 48:599-641
14. Grąt M, Hołówko W, Grzegorczyk K et al (2011) Long-term results of liver resection in the treatment of patients with hepatocellular carcinoma. Pol Przegl Chir 83:319-324
15. Grąt M, Kornasiewicz O, Lewandowski Z et al (2013) The impact of surgical technique on the results of liver transplantation in patients with hepatocellular carcinoma. Ann Transplant 18:448-459
16. Graham JA, Melancon JK, Shetty K et al (2013) Liver transplantation should be offered to patients with small solitary hepatocellular carcinoma and a positive serum alpha fetoprotein rather than resection. Am J Surg 205:374-380
17. Lee YH, Hsia CY, Hsu CY et al (2013) Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria. World J Surg 37:1348-1355
18. Eguchi S, Takatsuki M, Hidaka M et al (2010) Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg 34:1034-1038
19. Krawczyk M, Grąt M, Barski K et al (2012) 1000 liver transplantations at the Department of General, Transplant and Liver Surgery, Medical University of Warsaw-analysis of indications and results. Pol Przegl Chir 84:304-312
20. Kaido T, Ogawa K, Mori A et al (2013) Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma. Surgery 154:1053-1060
21. Fan J, Yang GS, Fu ZR et al (2009) Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. J Cancer Res Clin Oncol 135:1403-1412
22. Herrero JI, Sangro B, Pardo F et al (2008) Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transplant 14:272-278
23. Lei J, Yan L (2012) Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies. J Gastrointest Surg 16:2120-2125
24. de Ataide EC, Garcia M, Mattosinho TJ et al (2012) Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma. Transplant Proc 44:2438-2440
25. Kwon CH, Kim DJ, Han YS et al (2007) HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis 25:313-319
26. Zheng SS, Xu X, Wu J et al (2008) Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85:1726-1732
27. Toso C, Asthana S, Bigam DL et al (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database. Hepatology 49:832-838
28. Grat M, Kornasiewicz O, Hołówko W et al (2013) Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer. Transplant Proc 45:1899-1903
29. Duvoux C, Roudot-Thoraval F, Decaens T et al (2012) Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology 143:986-994
30. Yaprak O, Akyildiz M, Dayangac M et al (2012) AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 11:256-261
31. Han K, Tzimas GN, Barkun JS et al (2007) Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol 21:39-45
32. Dumitra TC, Dumitra S, Metrakos PP et al (2013) Pretransplantation α-fetoprotein slope and Milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation. Transplantation 95:228-233
33. Merani S, Majno P, Kneteman NM et al (2011) The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. J Hepatol 55:814-819
34. Witjes CD, Polak WG, Verhoef C et al (2012) Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers. Dig Surg 29:522-528
35. Fujiki M, Takada Y, Ogura Y et al (2009) Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant 9:2362-2371
36. Shindoh J, Sugawara Y, Nagata R et al (2014) Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma. Transpl Int 27:391-398